Status:
UNKNOWN
Percutaneous Ketamine Versus Lidocaine for Mid-Sternotomy
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Sternotomy
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Since midsternotomy is painful postoepratively, and since ketamine has been shown to be optimal postoeprative analgessic adjuvant, the investigators wish to assess its percutaneous preemptive effect, ...
Detailed Description
Ketamine hydrochlorid is a general anesthetic that is also used as short term sedative. Ketamine has an antagonistic effect on the central spinal N-Methyl-D-Aspartate (NMDA) receptors, the latter modu...
Eligibility Criteria
Inclusion
- all patients undergoing sternoromy for cardiac or chest sturgery
Exclusion
- emergency surgery
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00822419
Start Date
February 1 2009
End Date
December 1 2009
Last Update
January 14 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tel Aviv Sourasky Medical center
Tel Aviv, Israel, 64239